7th July 2017, Volume 130 Number 1458

Sharon J Gardiner, Jane A Pryer, Eamon J Duffy

Antimicrobial resistance is a recognised threat to modern medicine,1 and is a growing concern in New Zealand.2 Antimicrobial stewardship (AMS), a collection of co-ordinated strategies that aims to optimise the…

Subscriber content

The full contents of this page is only available to subscribers.

To view this content please login or subscribe

Summary

Antimicrobial resistance is a growing problem in New Zealand and means that antimicrobials are becoming less effective. Antimicrobial stewardship (co-ordinated strategies to help optimise the use of antimicrobials) can slow the progression of resistance. This survey shows that antimicrobial stewardship is in its infancy in New Zealand’s public hospitals, with only around half of our DHBs employing dedicated pharmacists and doctors to help optimise antimicrobial prescribing. Practices to improve antimicrobial prescribing (eg, audit, teaching, guideline development) are highly variable from DHB to DHB. National co-ordination is needed to help DHBs develop effective programmes to help preserve antimicrobials for future use.

Abstract

Aim

To determine what antimicrobial stewardship (AMS) practices exist in New Zealand public hospitals.

Method

A quantitative survey based on recommended components of hospital AMS programmes was sent to the 20 DHBs in June 2016.

Results

Ten of the 20 DHBs had an AMS committee, nine had dedicated AMS pharmacist full-time equivalents (FTEs) and eight had lead clinician FTEs. Only one DHB met FTE recommendations for AMS pharmacists and two for clinicians (0.3 and 0.1 FTEs per 100 acute beds, respectively). All DHBs had conducted at least one antimicrobial audit in the preceding 12 months, most had their own antimicrobial guidelines (19/20) and prescribing policies (18/20), and 12 reported on antimicrobial usage by at least one metric (eg, defined daily doses). Staff education on AMS had been given at most DHBs in the previous year, but only three reported having AMS ward rounds. All DHBs had surveillance programmes for resistant organisms and most produced antibiograms (16/20). All reported barriers to implementation of an AMS programme.

Conclusion

Hospital AMS programmes are in their infancy in New Zealand, with wide variation in practices seen. National co-ordination is required to assist DHBs in developing effective programmes to improve antimicrobial use.

Author Information

Sharon J Gardiner, Antimicrobial Stewardship Pharmacist, Departments of Pharmacy, Infectious Diseases and Clinical Pharmacology, Canterbury District Health Board; Jane A Pryer, Senior Advisor, Protection Regulation and Assurance, Ministry of Health; Eamon J Duffy, Antimicrobial Stewardship Pharmacist, Departments of Pharmacy and Infectious Diseases, Auckland District Health Board, and member of Healthcare Associated Infections Governance Group, Ministry of Health.

Correspondence

Sharon J Gardiner, Department of Infectious Diseases, Christchurch Hospital, PB 4710, Christchurch.

Correspondence Email

sharon.gardiner@cdhb.health.nz

Competing Interests

Nil.

References

  1. World Health Organisation. Global Action Plan on Antimicrobial Resistance. Geneva, Switzerland, 2015. Available at: http://www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng.pdf
  2. Williamson DA, Heffernan H. The changing landscape of antimicrobial resistance in New Zealand. N Z Med J. 2014; 127:41–54.
  3. Howard P, Pulcini C, Levy Hara G, et al on behalf of the ESCMID Study Group for Antimicrobial Policies (ESGAP) and ISC Group on Antimicrobial Stewardship. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother. 2015; 70:1245–55.
  4. Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2013; 4: CD003543. doi: 10.1002/14651858.CD003543.pub3.
  5. Duguid M, Cruickshank M. Antimicrobial Stewardship in Australian Hospitals. Australian Commission on Safety and Quality in Health Care, Sydney, Australia, 2010. Available at http://www.safetyandquality.gov.au/wp-content/uploads/2011/ 01/Antimicrobial-stewardship-in-Australian-Hospitals-2011.pdf
  6. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016; 62: e51-77. doi: 10.1093/cid/ciw118.
  7. Centers for Disease Control and Prevention. Core Elements of Hospital Antibiotic Stewardship Programs. Atlanta, United States of America, 2014. Available at http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html
  8. Ministry of Health. Antimicrobial resistance. Wellingon, New Zealand. Available at: http://www.health.govt.nz/our-work/diseases-and-conditions/antimicrobial-resistance [Accessed 02 February 2017].
  9. Thompson I. Antimicrobial Stewardship in New Zealand: Scoping Research. Health Quality and Safety Commission, Wellington, New Zealand, 2013. Available at: http://www.hqsc.govt.nz/assets/Infection-Prevention/PR/Antimicrobial-stewardship-report.pdf
  10. Duffy E, Gardiner S, du Plessis T, Bondesio K, Morar B. A snapshot of antimicrobial use in New Zealand hospitals-a comparison to Australian and English data. N Z Med J. 2015; 128:82–4.
  11. Standards New Zealand. Health and Disability Services (Infection Prevention and Control) Standards. NZS 8134.3:2008. Ministry of Health, Wellington, New Zealand, 2008. Available at: http://www.health.govt.nz/system/files/documents/pages/81343-2008-nzs-health-and-disability-services-infection-prevention-and-control.pdf
  12. Healthcare Associated Infections Governance Group, Ministry of Health, New Zealand. See: http://www.health.govt.nz/about-ministry/leadership-ministry/expert-groups/healthcare-associated-infections-governance-group [Accessed 16 February 2017].
  13. Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infectious Dis 2014; 14:742–50. doi: 10.1016/S1473-3099(14)70780-7.
  14. Williamson DA, Roos RV, Verrall A. Antibiotic consumption in New Zealand, 2006–2014. Institute of Environmental Science and Research Limited, Porirua, New Zealand. 2016. Available at: http://surv.esr.cri.nz/PDF_surveillance/AntibioticConsumption/2014/Antibiotic_Consumption_Report_Final.pdf
  15. Public Health England. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). London, England. 2016. Available at: http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/575626/ESPAUR_Report_2016.pdf
  16. Fridkin SK, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014; 63:194–200.
  17. Australian Commission on Safety and Quality in Healthcare. National Safety and Quality Health Service Standards. Sydney, Australia, 2012. Available at http://www.safetyandquality.gov.au/wp-content/uploads/2011/09/NSQHS-Standards-Sept-2012.pdf
  18. Australian Commission on Safety and Quality in Health Care. Antimicrobial Stewardship Clinical Care Standard. Sydney, Australia, 2014. Available at: http://www.safetyandquality.gov.au/wp-content/uploads/2014/11/Antimicrobial-Stewardship-Clinical-Care-Standard-web.pdf
  19. Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Therapeutic Guidelines Limited, Melbourne, Australia. 2014. 

Download

The downloadable PDF version of this article is only available to subscribers.

To view this content please login or subscribe